Cargando…

P1408: UPDATED RESULTS OF THE PHASE I BALLI-01 TRIAL OF UCART22, AN ANTI-CD22 ALLOGENEIC CAR-T CELL PRODUCT, IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) CD22+ B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)

Detalles Bibliográficos
Autores principales: Boissel, Nicolas, Chevallier, Patrice, Curran, Kevin, Schiller, Gary, Liu, Hongtau, Larson, Richard, Deangelo, Daniel J., Mear, Jean-Baptiste, Grupp, Stephan, Baruchel, André, Konopleva, Marina, Lacroce, Alexandra, Roudet, Caroline, Korngold, Ana, Newhall, Katie, Laille, Eric, Lee, Daniel, Frattini, Mark, Jain, Nitin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430638/
http://dx.doi.org/10.1097/01.HS9.0000972520.32337.3f